rss
J Clin Pathol 2005;58:1185-1188 doi:10.1136/jcp.2005.026906
  • Original article

CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast

  1. G M K Tse1,
  2. P-H Tan2,
  3. T K F Ma3,
  4. C B Gilks4,
  5. C S P Poon3,
  6. B K B Law5
  1. 1Departments of Anatomical and Cellular Pathology, Prince of Wales Hospital, Chinese University of Hong Kong, Ngan Shing Street, Shatin, NT Hong Kong, SAR
  2. 2Department of Pathology, Singapore General Hospital, Singapore
  3. 3Department of Pathology, North District Hospital, Hong Kong, SAR
  4. 4Department of Pathology, Vancouver General Hospital, Vancouver, BC V52 1M9, Canada
  5. 5Breast Centre, Union Hospital, Hong Kong, SAR
  1. Correspondence to:
 Dr G M K Tse
 Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Chinese University of Hong Kong, Ngan Shing Street, Shatin, NT, Hong Kong SAR; garytsecuhk.edu.hk
  • Accepted 6 March 2005

Abstract

Background/Aims: CD44s, the standard form of CD44, has been shown to be downregulated during malignant transformation of breast cancers. It has also been reported recently to be a useful marker in differentiating between benign and malignant papillary lesions of the breast, with high expression in the former. CD44s expression in benign and malignant papillary lesions was evaluated.

Methods: CD44s expression was assessed by immunohistochemistry in 101 benign papillomas and 59 papillary carcinomas (seven invasive papillary carcinomas, 41 papillary ductal carcinomas in situ, and 11 ductal carcinomas involving papillomas).

Results: Patients’ age and tumour size were significantly different between the papilloma and papillary carcinoma groups (p < 0.0001). CD44s showed positive staining in 45 papillomas (45%) and five papillary carcinomas (8%), and the difference was significant (p < 0.0001). The myoepithelial cells, when present, were also positive for CD44s in both groups, with no observable differences. Using CD44s positive staining to differentiate between benign and malignant papillary lesions gives a sensitivity, specificity, and accuracy of 45%, 92%, and 62%, respectively.

Conclusions: CD44s may be useful as an adjunct in the evaluation of morphologically problematic cases of papillary lesion of the breast.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.